Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
Invesco India Flexi Cap Fund Reg (G)
[Equity: Flexi Cap]  
 
Fund Details
Fund Type Growth Launch Date 14-Feb-2022
Corpus(Cr.) 2573.0 Latest NAV 18.31 As on 30-05-2025
Equity(%) 96.94 52 Week High 19.5
Debt(%) 3.06 52 Week Low 15.39
Others(%) 0.0 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.95
Scheme Benchmark BSE 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Amit Ganatra
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate capital appreciation by dynamically investing in a mix of equity and equity related instruments across market capitalization i.e. large, mid and small cap stocks.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 24.96%
Top 10 Holdings 39.84%
Top 25 Holdings 69.87%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 19.58
Retail 10.35
Finance & Investments 9.7
Software & Services 7.91
Automobile 6.77
Pharma & Biotech 5.61
Healthcare 5.11
Consumer Durables 4.15
Industrial Products 4.07
Aerospace & Defence 3.92
Construction 3.83
Telecom 3.81
Transportation 3.28
Cash 3.06
Food Beverage & Tobacco 2.98
Electricals 2.0
Technology 1.52
Communication 1.39
Chemicals 0.57
Consumer Non Durable 0.34
SERVICES 0.05
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.97
PE Ratio 37.29
 
Top 25 Holdings
Holdings Net Asset(%)
ICICI Bank Limited 8.92
HDFC Bank Limited 5.37
Cholamandalam Invest & Finance Co Ltd 3.99
Trent Limited 3.40
Inter Globe Aviation Ltd 3.28
Triparty Repo 3.24
Infosys Limited 3.21
Zomato Limited 2.93
Bajaj Finance Limited 2.89
Bharat Electronics Limited 2.61
Coforge Limited 2.59
Max Healthcare Institute Limited 2.33
TVS Motor Co Ltd 2.29
Bharti Airtel Limited 2.26
Larsen & Toubro Limited 2.24
DIXON TECHNOLOGIES (INDI LTD 2.24
Varun Beverages Limited 2.22
Hitachi Energy India Limited 2.00
MANKIND PHARMA LIMITED 1.97
Mahindra & Mahindra Limited 1.92
Persistent Systems Limited 1.63
Bombay Stock Exchange Limited (BSE) 1.62
J K CEMENT LTD 1.59
Suven Pharmaceuticals Limited 1.57
EQ- GLOBAL HEALTH LTD. 1.56

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
5.23% 16.85% -1.56% 14.80%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [BSE 500 TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
28.49% 23.93% 0.00% 0.00%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection